The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects

NCT05786066 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Depressive Disorder
Major Depressive Disorder
Bipolar Disorder
Post Traumatic Stress Disorder
Suicidal Ideation

Interventions

DRUG: Perampanel 6 MG
DRUG: Ketamine
DRUG: Placebo

Sponsor

Yale University

Collaborators

[object Object]
[object Object]
[object Object]